Clinical trial
Prospective, Multi-center, Randomized Controlled Study to Evaluate the Effectiveness and Safety of Endovenous Radiofrequency Ablation Closure System in the Treatment of Varicose Veins
NCT04671641 is registered in ClinicalTrials.gov with Suzhou Hengruihongyuan Medical Technology Co. LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multi-center, Randomized Controlled Study to Evaluate the Effectiveness and Safety of Endovenous Radiofrequency Ablation Closure System in the Treatment of Varicose Veins
- Lead sponsor
- Suzhou Hengruihongyuan Medical Technology Co. LTD
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 24, 2021
- Completion date
- July 1, 2022
- Enrollment
- 176 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.